Natalizumab Injection 300 mg Suppliers & Bulk Manufacturers
Available Forms: IV Injection
Available Strengths: 300 mg
Reference Brands: Tysabri(US & EU)
Category: Multiple sclerosis
Natalizumab is a monoclonal antibody that blocks α4-integrin, preventing immune cells from crossing the blood-brain barrier. It reduces inflammation, decreases MS relapses, and slows disease progression. Benefits include effective disease control, fewer relapses, and improved quality of life for patients with relapsing multiple sclerosis.
Product Description:
Natalizumab injection, marketed as Tysabri, is approved in the US by the FDA and in the EU via EMA for multiple sclerosis and Crohn’s disease. Regulatory approval requires a comprehensive dossier including clinical efficacy, safety data, manufacturing quality, and pharmacovigilance plans. In the US, the FDA reviews detailed clinical trial and safety data, while the EMA ensures compliance with regional safety and quality standards.
Natalizumab Injection — third party manufacturing & bulk supply
Natalizumab Injection 300 mg is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:
What to include when you enquire
- Destination market — determines which manufacturers hold the right site-level approvals
- First order quantity and estimated annual volume
- Whether you need a registration dossier or the product is already registered
- Packaging, labelling and language requirements
- Incoterms and required shelf life
Manufacturers of Natalizumab Injection listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding. Narcotic drugs and controlled substances are supplied strictly against valid import and export permits issued by the competent authorities.
Request a quote for Natalizumab Injection →The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Frequently Asked Questions
Natalizumab is used for treating relapsing forms of multiple sclerosis (MS) to reduce the frequency of relapses and delay disability progression. It is also used for moderate to severe Crohn’s disease in adults who have not responded adequately to conventional therapies.
Natalizumab is a humanized monoclonal IgG4 antibody that binds to the α4 subunit of integrins on leukocytes, blocking their adhesion to vascular endothelium and preventing migration into the central nervous system and inflamed intestinal tissue.
Tysabri.
Biogen Inc. (co-developed with Elan Pharmaceuticals).
Natalizumab.
Tysabri.
Manufactured in the USA and distributed globally, including the EU, Japan, and other regions.
Related Products
Lamotriginevdispersible Tablets
Strength:
XR: 25 mg, 50 mg, 100 mg, 200 mg; IR: 25 mg, 100 mg, 200 mg, 300 mg
Form: Tablets(IR & ER)
Reference Brands: Lamictal, Lamictal XR(EU & US)
View Details
Dalfampridine
Strength:
10 mg
Form: Extended-Release tablets (XR)
Reference Brands: Ampyra(US)
View Details
Tizanidine Tablets/Capsules
Strength:
2 mg and 4 mg
Form: Oral Capsules/Tablets
Reference Brands: Zanaflex (US)
View Details
Baclofen Tablets:
Strength:
10 mg and 20 mg
Form: Tablet
Reference Brands: Lioresal, Gablofen(US & EU)
View DetailsQuick Response Guaranteed | Verified Suppliers
